NCT00024089View on ClinicalTrials.gov

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

March 31, 2006

Conditions
Head and Neck Cancer
Interventions
DRUG

gefitinib

Trial Locations (1)

84112

Huntsman Cancer Institute at University of Utah, Salt Lake City

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00024089 - Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | Biotech Hunter | Biotech Hunter